High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel-Reference-Cited by-同舟云学术

High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel

Published:2015-08-28 Issue:8 Volume:10 Page:e0135037
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Geisler Tobias,Booth Jean,Tavlaki Elli,Karathanos Athanasios,Müller Karin,Droppa Michal,Gawaz Meinrad,Yanez-Lopez Monica,Davidson Simon J.,Stables Rod H.,Banya Winston,Zaman Azfar,Flather Marcus,Dalby Miles

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Prasugrel versus clopidogrel in patients with acute coronary syndromes;SD Wiviott;N Engl J Med,2007

2. ACTION Group Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis;A1 Bellemain-Appaix;JAMA,2012

3. Genetic variation of platelet function and pharmacology: an update of current knowledge;T Geisler;Thromb Haemost,2013

4. A prospective observational study of treatment practice patterns in acute coronary syndrome patients undergoing percutaneous coronary intervention in Europe;76-87 Ferri;Arch Cardiovasc Dis,2011

5. Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study;G Montalescot;Thromb Haemost,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning insights into thrombo-ischemic risks and bleeding events through platelet lysophospholipids and acylcarnitine species;Scientific Reports;2024-03-13

2. Monitoring of Antiplatelet Therapy;Methods in Molecular Biology;2023

3. Ticagrelor and prasugrel in acute coronary syndrome: a single-arm crossover platelet reactivity study;Journal of Cardiovascular Medicine;2021-07-16

4. Prasugrel in the treatment of acute coronary syndrome;Future Cardiology;2020-11

5. Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor;Vascular Pharmacology;2020-09